De Vries EG - Search Results

1

Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium.

Mourits MJ, Hollema H, De Vries EG, Ten Hoor KA, Willemse PH, Van Der Zee AG. Mourits MJ, et al. Among authors: de vries eg. Hum Pathol. 2002 Mar;33(3):341-6. doi: 10.1053/hupa.2002.32226. Hum Pathol. 2002. PMID: 11979376

2

The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.

Mourits MJ, Ten Hoor KA, van der Zee AG, Willemse PH, de Vries EG, Hollema H. Mourits MJ, et al. Among authors: de vries eg. J Clin Pathol. 2002 Jul;55(7):514-9. doi: 10.1136/jcp.55.7.514. J Clin Pathol. 2002. PMID: 12101196 Free PMC article.

3

Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.

Reesink-Peters N, Hougardy BM, van den Heuvel FA, Ten Hoor KA, Hollema H, Boezen HM, de Vries EG, de Jong S, van der Zee AG. Reesink-Peters N, et al. Among authors: de vries eg, de jong s. Gynecol Oncol. 2005 Mar;96(3):705-13. doi: 10.1016/j.ygyno.2004.10.046. Gynecol Oncol. 2005. PMID: 15721415

4

Effect of tamoxifen on the endometrium and the menstrual cycle of premenopausal breast cancer patients.

Buijs C, Willemse PH, de Vries EG, Ten Hoor KA, Boezen HM, Hollema H, Mourits MJ. Buijs C, et al. Among authors: de vries eg. Int J Gynecol Cancer. 2009 May;19(4):677-81. doi: 10.1111/IGC.0b013e3181a47cbe. Int J Gynecol Cancer. 2009. PMID: 19509569

5

Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.

Mourits MJ, Van der Zee AG, Willemse PH, Ten Hoor KA, Hollema H, De Vries EG. Mourits MJ, et al. Among authors: de vries eg. Gynecol Oncol. 1999 Apr;73(1):21-6. doi: 10.1006/gyno.1998.5316. Gynecol Oncol. 1999. PMID: 10094875

6

Ovarian cysts in women receiving tamoxifen for breast cancer.

Mourits MJ, de Vries EG, Willemse PH, ten Hoor KA, Hollema H, Sluiter WJ, de Bruijn HW, van der Zee AG. Mourits MJ, et al. Among authors: de vries eg, de bruijn hw. Br J Cancer. 1999 Apr;79(11-12):1761-4. doi: 10.1038/sj.bjc.6690280. Br J Cancer. 1999. PMID: 10206289 Free PMC article.

7

Tamoxifen treatment and gynecologic side effects: a review.

Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG. Mourits MJ, et al. Among authors: de vries eg. Obstet Gynecol. 2001 May;97(5 Pt 2):855-66. doi: 10.1016/s0029-7844(00)01196-0. Obstet Gynecol. 2001. PMID: 11336777 Review.

8

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy.

Mourits MJ, Böckermann I, de Vries EG, van der Zee AG, ten Hoor KA, van der Graaf WT, Sluiter WJ, Willemse PH. Mourits MJ, et al. Among authors: de vries eg. Br J Cancer. 2002 May 20;86(10):1546-50. doi: 10.1038/sj.bjc.6600294. Br J Cancer. 2002. PMID: 12085202 Free PMC article.

9

Side effects of therapy: case 2. Tamoxifen and uterine abnormalities.

Buijs C, Willemse PH, Tinga DJ, Hollema H, de Vries EG, Mourits MJ. Buijs C, et al. Among authors: de vries eg. J Clin Oncol. 2004 Jun 15;22(12):2505-7. doi: 10.1200/JCO.2004.07.123. J Clin Oncol. 2004. PMID: 15197214 No abstract available.

10

Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer.

Hofstra LS, Bos AM, de Vries EG, van der Zee AG, Willemsen AT, Rosing H, Beijnen JH, Mulder NH, Aalders JG, Willemse PH. Hofstra LS, et al. Among authors: de vries eg. Gynecol Oncol. 2002 Jun;85(3):517-23. doi: 10.1006/gyno.2002.6665. Gynecol Oncol. 2002. PMID: 12051884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

982 results

Search Page

Filters